# Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

> **NCT06615596** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 3160 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)

## Interventions

- **BEHAVIORAL:** discontinue anticoagulation therapy
- **DRUG:** Anticoagulant drugs
- **PROCEDURE:** Catheter Ablation

## Key facts

- **NCT ID:** NCT06615596
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2029-01
- **Final completion:** 2029-12
- **Target enrollment:** 3160 (ESTIMATED)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06615596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06615596, "Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06615596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*